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What this paper adds 
 
What is already known on this subject 
Implementation of comprehensive smoke-free legislation is associated with significant early-life 
health benefits, including reductions in severe paediatric respiratory events. 
Evidence on the impact of national policies typically is derived from quasi-experimental studies; 
given their inherent risks of bias and confounding, replication of such studies across various 
settings is essential. 
What this study adds 
We investigated if the March 2006 national implementation of comprehensive smoke-free 
legislation in Scotland was associated with a reduction in hospital admissions/deaths due to acute 
respiratory tract infections among children. 
Our pre-specified interrupted time series approach suggested that implementation of smoke-free 
legislation in Scotland was associated with an increase in paediatric respiratory tract infection 
admissions/deaths.  
We were concerned that this result, which contradicted published evidence, was spurious. The 
association was indeed reversed when accounting for an unanticipated antecedent breakpoint in 
the temporal trend, suggesting that the legislation may in fact be protective. 
We discuss the findings from this national study and propose approaches to enhancing the 
methodological quality of interrupted time series studies.  
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ABSTRACT 
 
Objectives 
We investigated whether Scottish implementation of smoke-free legislation was associated with a 
reduction in unplanned hospitalisations or deaths (‘events’) due to respiratory tract infections 
(RTIs) among children. 
 
Design 
Interrupted times series (ITS) 
 
Setting/participants 
Children aged 0-12 years living in Scotland during 1996-2012 
 
Intervention 
National comprehensive smoke-free legislation (March 2006) 
 
Main outcome measure 
Acute RTI events in the Scottish Morbidity Record-01 and/or National Records of Scotland 
Death Records 
 
Results 
135,134 RTI events were observed over 155 million patient-months. In our pre-specified negative 
binomial regression model accounting for underlying temporal trends, seasonality, sex, age 
group, region, urbanisation level, socioeconomic status, and seven-valent pneumococcal 
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vaccination status, smoke-free legislation was associated with an immediate rise in RTI events 
(incidence rate ratio (IRR)=1.24, 95%CI 1.20-1.28) and an additional gradual increase 
(IRR=1.05/year, 95%CI 1.05-1.06). Given this unanticipated finding we conducted a number of 
post-hoc exploratory analyses. Among these, automatic breakpoint detection indicated that the 
rise in RTI events actually preceded the smoke-free law by 16 months. When accounting for this 
breakpoint, smoke-free legislation was associated with a gradual decrease in acute RTI events: 
IRR=0.91/year, 95%CI 0.87-0.96. 
 
Conclusions 
Our pre-specified ITS approach suggested that implementation of smoke-free legislation in 
Scotland was associated with an increase in paediatric RTI events. We were concerned that this 
result, which contradicted published evidence, was spurious. The association was indeed reversed 
when accounting for an unanticipated antecedent breakpoint in the temporal trend, suggesting 
that the legislation may in fact be protective. ITS analyses should be subjected to comprehensive 
robustness checks to assess consistency.  
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BACKGROUND 
 
Tobacco smoking continues to cause a considerable burden of death and disease worldwide.[1,2] 
It is estimated that 40-50% of children globally are regularly exposed to second-hand smoke 
(SHS).[3,4] They are particularly vulnerable to the adverse effects of SHS exposure as their 
bodies are still undergoing development and, especially when very young, cannot influence their 
own degree of exposure. Among children under five years of age, exposure to SHS has been 
estimated to cause 165,000 deaths and almost six million disability-adjusted life years (DALYs) 
annually through lower respiratory tract infections (RTIs) alone.[3] Additional adverse paediatric 
health outcomes associated with SHS exposure include otitis media with effusion,[5] invasive 
meningococcal disease,[6] and wheezing disorders including asthma.[7,8] 
 
There is a pressing need to identify effective approaches to reducing child SHS exposure and 
through so doing improve child health. The effectiveness of individual or family-level 
interventions to reduce SHS exposure has generally been disappointing.[9] At a population level, 
governmental policies aimed at reducing tobacco smoking and SHS exposure have the potential 
to also reduce child SHS exposure. Comprehensive smoke-free laws and tobacco tax increases 
have been shown to be associated with improved respiratory health among children.[10-13] 
Evaluation of the effectiveness of such policies is however complicated by the fact that they are 
generally not amendable to implementation in a randomised fashion.[14] 
 
Quasi-experimental studies, such as interrupted time series (ITS) studies, are advocated as a next 
best alternative to randomised designs when evaluating the impact of population-level policy 
changes.[15] Attribution of causality is however challenging because of the inherent risks of bias 
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and confounding. Findings are in addition sensitive to choice and specification of the statistical 
modelling technique used. Pre-specification of a detailed statistical analysis plan has been 
advocated to reduce the associated risk of data dredging, to encourage publication irrespective of 
a study’s findings, and to promote the reproducibility of science.[16,17] 
 
We investigated whether the implementation of comprehensive smoke-free legislation in 
Scotland was associated with changes in the number of unplanned paediatric hospitalisations or 
deaths due to RTIs. Introduction of the Scottish smoke-free law was followed by significant 
reductions in reported SHS exposure in public places and the home environment among school-
age children, along with a –40% (95%CI –47; –32, p<0.001) reduction in mean salivary cotinine 
concentrations.[18] Previous studies in England, Hong Kong and the United States have 
identified significant reductions in hospital admissions for acute RTIs among children following 
introduction of smoke-free laws.[10,12,19,20] Based on these previous studies and the wider 
evidence of the health impact of smoke-free legislation,[11,21-24] we hypothesised that the 
Scottish smoke-free law would be associated with a reduction in acute RTI events.  
 
 
METHODS 
 
This study was conducted according to a protocol developed a priori (National Services Scotland 
reference: PAC 04/12 IR – XRB13092; Supplementary File 1). We analysed the association 
between introduction of smoke-free legislation in Scotland and the incidence rate of unplanned 
hospital admissions or deaths due to acute RTIs among children aged ≤12 years. STROBE and 
RECORD statements were followed to guide reporting.Given use of fully anonymised routinely 
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collected health care data, we received an exemption from formal ethical assessment for this 
study. 
 
Smoke-free legislation 
On 26 March 2006, a national law came into force overnight in Scotland prohibiting smoking in 
enclosed public places (i.e. bars; restaurants; hotels; shops; shopping centres; libraries; archives; 
museums; galleries; entertainment premises (e.g. cinemas; concert halls; theatres; gaming and 
amusement arcades; discotheques); film studios; assembly halls; conference centres; exhibition 
halls; public toilets; clubs premises; educational institutions (e.g. schools); care homes and 
shelters; health care premises (e.g. hospitals); child care premises (e.g. nurseries); religious 
premises (e.g. churches); sports centres; public transportation facilities (e.g. airports) and 
vehicles; public telephone kiosks) and workplaces (including offshore facilities and work 
vehicles), with very few exemptions (i.e. residential accommodation; designated rooms in adult 
care homes and adult hospices; designated rooms in psychiatric hospitals and psychiatric units; 
designated hotel bedrooms; designated detention or interview rooms; designated laboratory 
rooms; Her Majesty’s submarines and ships of the Royal Fleet Auxiliary; private vehicles).[25] 
Of inspected premises, 96-99% were compliant with the law in the first year following the law’s 
introduction, and 94-97% and 95-97% in the second and third year, respectively.[26] 
 
Study population and period 
We included data from all children aged ≤12 years who were resident in Scotland at any time 
during the study period and had not yet experienced an RTI event before the study period. 
Children aged 13 years and above were excluded in an attempt to limit potential confounding by 
active smoking. We included data on all first unplanned hospital admissions or deaths due to 
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acute RTIs (composite outcome: ‘events’) occurring between 1 January 1996 and 31 December 
2012 (i.e. the most recent data available at the time of data extraction). 
 
Outcome definitions 
Our primary outcome was the incidence rate of acute RTI events. Deaths were included to 
account for children that died due to an acute RTI before having reached the hospital. Secondary 
outcomes were the separate incidence rates of upper and lower RTI events. In these analyses, 
events that contained both a code for an upper and a lower RTI were counted as lower RTI 
events. For the purpose of this study, an event was considered to be associated with an acute RTI 
if this had been registered as either a primary or secondary diagnosis. The following International 
Classification of Diseases-10 codes were included: upper RTIs: A37, H66-67, J00-06, J09-11 
(not J10.0/J11.0); lower RTIs: J10.0/J11.0, J12-18, J20-22, J40-42 (Supplementary File 2). To 
avoid contamination of our outcome of interest with asthma exacerbations which may or may not 
have been due to RTIs, events where asthma was recorded as the primary diagnosis were 
excluded. In order to prevent dependency of data due to individual children experiencing multiple 
RTI events during the study period, only first events (i.e. admission or death, whichever came 
first) were included. For eligible children born before start of th  study period (i.e. 1 January 
1996) a look-back period of 12 years was applied to determine whether the child previously 
experienced an acute RTI hospitalisation.  
 
Data sources 
Data on acute RTI hospitalisations were retrieved from the Scottish Morbidity Record 01 
(SMR01), a national database collecting data on all hospital admissions among Scottish residents. 
Deaths due to acute RTIs were identified from National Records of Scotland Death Records. Data 
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on individual pneumococcal conjugate vaccine (PCV) vaccination status were retrieved from the 
Scottish Immunisation and Recall System database, which collects national vaccination data. 
Individual-level data were linked across the different databases by electronic Data Research and 
Innovation Service (eDRIS) staff at Information Services Division Scotland using the unique 
Community Health Index (CHI) identifier before being made available to the researchers. Air 
quality data were obtained from the UK Governmental Department for Environment Food and 
Rural Affairs (DEFRA) and linked to the main data document by the researchers.[27] 
 
Data handling and covariates 
The numbers of children at risk and those experiencing a first acute RTI event were aggregated 
by eDRIS staff into strata based on all possible combinations of the following covariates: month; 
year; sex (male; female); age group (<5 years; ≥5 years); region (according to health board of 
residence: South-West; South-East; North); urbanisation level (according to residential post code: 
urban; rural); socioeconomic status (quintiles of Scottish Index of Multiple Deprivation (SIMD 
[28]; 2006 version) based on residential postcode); PCV vaccination (yes; no). On 4 September 
2006, PCV was introduced into the childhood immunisations schedule at two, four, and 13 
months of age, with a catch-up programme for children born from 5 September 2004.[29] Given 
the close temporal proximity of PCV introduction to that of the smoke-free law in Scotland we 
linked data on RTI events to PCV vaccination status at an individual level to address potential 
confounding.[10] 
 
In a post-hoc analysis we used air quality data for all Scottish monitoring sites that collected data 
during the study period: carbon monoxide (CO; mg/m
3
); nitric oxide (NO; µg/m
3
); nitrogen 
dioxide (NO2; µg/m
3
); nitrogen oxides as NO2 (µg/m
3
); sulphur dioxide (SO2; µg/m
3
); ozone (O3; 
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µg/m
3
); particulate matter of diameter <10µm (PM10; µg/m
3
). For each monitoring site, mean 
monthly values were calculated from mean daily values and missing values were imputed using 
linear interpolation. Availability of air quality data from fixed stations was patchy both across 
time and the different monitoring sites, hampering combination of data across sites. Fairly 
consistent data throughout the study period was only available for Glasgow city centre. 
 
Statistical analyses 
Negative binomial regression analysis was pre-specified as our primary analysis, in which the 
number of acute RTI events was the dependent variable. Predictors included: time (a continuous 
variable ranging from ‘1’ in January 1996 to ‘204’ in December 2012, designed to account for the 
underlying temporal trend in acute RTI events); timing of the smoke-free law (a dummy variable 
coded ‘0’ prior to March 2006 and ‘1’ otherwise); an interaction variable ‘time × smoke-free law’ 
(to account for a change in temporal trend in acute RTI events following the law); month (a 
categorical variable to account for seasonality); sex; age group; region; urbanisation level; SIMD 
quintile; PCV vaccination. Akaike’s information criterion (AIC) was used to select the optimal 
model among three options according to the temporal change in RTI events following the smoke-
free law: immediate (‘step’) change; gradual (‘slope’) change; step + slope change. The size of 
the population at risk was used as an offset in the models. We modelled acute RTI events using 
three variants of negative binomial regression; NB1 (constant dispersion), NB2 (mean dispersion) 
and NBP (“NB rho”) which uses a second dispersion parameter that is allowed to vary freely 
across the data observations.[30] The most appropriate negative binomial variant was selected 
using AIC. We tested for non-linear time effects using a restricted cubic spline with four degrees 
of freedom compared with one degree of freedom using the ‘mvrs’ module in Stata.[31] In 
Page 11 of 45
https://mc.manuscriptcentral.com/tobaccocontrol
Tobacco Control
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
12 
 
November 2003 there was an unusually high incidence of RTI events, which was modelled using 
a dummy variable.  
 
Post-hoc exploratory analyses 
We performed a number of exploratory post-hoc analyses to assess the robustness of the findings 
from our primary analyses, which were felt to be implausible (discussed below).  
 
First, we performed stratified analyses according to age group and sex to explore whether the 
association between smoke-free legislation and acute RTI events differed across categories of 
these variables. Young age and male sex are important risk factors for RTIs in childhood. 
 
Second, we explored whether the association between smoke-free legislation and RTI events was 
robust to accounting for temporal trends in air quality. Given the patchiness of air quality 
availability, we performed an exploratory analysis adding Glasgow city centre air quality data as 
parameters to the model, using data on acute RTI events occurring in South-West Scotland only. 
Backward selection of air quality indicators was based on AIC. 
 
Third, we ran time series regressions on the acute RTI events with seasonal autoregressive 
integrated moving average ((S)ARIMA) errors to account for regular and seasonal autoregression 
in the data. The models contained an underlying trend, a dummy variable for the post-ban period 
and a post-ban temporal trend, allowing a number of intervention effects to be tested. Again, we 
tested for non-linear time effects using Stata’s ‘mvrs’ module.[31] Candidate error models were 
identified from autocorrelation and partial autocorrelation plots. The most appropriate model was 
selected using the AIC statistic and was subjected to standard diagnostic tests for white noise 
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residuals using the Ljung-Box Portmanteau statistic as well as graphically using auto-correlation 
plots and correlograms.[32] 
 
Fourth, we tested for structural breaks in the time series data using Stata’s ‘estat sbsingle’ 
command. The procedure searches for a possible trend break over a stipulated range of dates by 
calculating the value of the test statistic (Wald or likelihood ratio) at each date and then using the 
maximum value of the test statistic to identify the potential break.[33] For the test to work, the 
series needed to be trimmed prior to the search so as to avoid using dates too close to the end or 
beginning of the series which would result in breakdown of the procedure. After 20% trimming 
we tested for a break in the intercept (step change) as well as a break in the trend (slope change). 
As a test of robustness we used the econometrics software EViews to also check for a structural 
break using its comprehensive suite of breakpoint detection options with 20% trimming of the 
data. The selected breakpoint and its form (step and/or slope) was then included as an additional 
regressor in the negative binomial model and the models re-estimated. 
 
All analyses were performed within the National Services Scotland’s Safe Haven environment 
using Stata MP version 14 except for the (S)ARIMA models. These were analysed separately on 
aggregated data which were supplied to the authors by the NSS Safe Haven after statistical 
disclosure control. The (S)ARIMA models and the structural break analysis were developed 
using Stata SE version 14 with the structural break point further corroborated using EViews 9.5. 
 
 
RESULTS 
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During 155 million patient-months of observation, 135,134 acute RTI events were recorded: 
79,153 upper RTI events and 56,011 lower RTI events. There was substantial variation in the 
incidence rate of acute RTI events over time (Figure 1) and across demographic subgroups (Table 
1). 
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Table 1. Demographic characteristics of children experiencing an acute respiratory tract 
infection event 
Characteristic Acute RTI events (n) 
 
Mean monthly acute upper 
RTI event rate (per 1000 
children) 
 Upper 
RTIs 
(n=79,153) 
Lower 
RTIs  
(n=56,011) 
All RTIs 
(n=135,134) 
Upper 
RTIs 
(0.51) 
Lower 
RTIs 
(0.36) 
All 
RTIs 
(0.87) 
Sex       
   Male 46,116 31,912 78,028 0.58 0.40 0.98 
   Female 33,007 24,099 57,106 0.43 0.32 0.76 
Age       
   0-4 years 67,462 51,109 118,571 1.16 0.88 2.05 
   5-12 years 11,661 4,902 16,563 0.12 0.05 0.17 
Region       
   North 28,074 18,257 46,332 0.57 0.37 0.93 
   South-West 34,496 23,759 58,255 0.50 0.34 0.84 
   South-East 16,553 13,994 30,547 0.46 0.39 0.86 
Urbanisation level       
   Urban 64,939 46,739 111,678 0.51 0.37 0.89 
   Rural 14,184 9,272 23,456 0.49 0.32 0.81 
Socio-economic 
status 
      
   Quintile 1 (most 
affluent) 
12,508 8,928 21,436 0.41 0.30 0.71 
   Quintile 2 14,507 9,693 24,200 0.48 0.32 0.81 
   Quintile 3 14,808 10,043 24,851 0.50 0.34 0.84 
   Quintile 4 16,849 11,658 28,507 0.57 0.39 0.96 
   Quintile 5 (most 
deprived) 
20,451 15,689 36,140 0.58 0.45 1.03 
PCV vaccination 
status 
      
   PCV received 13,324 5,619 18,943 0.69 0.19 0.88 
   PCV not 
received 
65,799 50,392 116,191 0.47 0.39 0.86 
PCV = pneumococcal conjugate vaccine; RTI = respiratory tract infection 
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In our primary analysis, introduction of smoke-free legislation was associated with an immediate 
rise in acute RTI events (incidence rate ratio (IRR) 1.24, 95% confidence interval (CI) 1.20-1.28) 
and an additional gradual increase over time (IRR 1.06 per year, 95%CI 1.05-1.06; Table 2). This 
finding was consistent when upper and lower RTI events were considered separately (Table 1 and 
Supplementary File 3). 
 
Post-hoc subgroup analyses to assess whether the unanticipated findings were confined to certain 
subgroups demonstrated consistency across sex and age subgroups (Supplementary File 4 and 5). 
In an analysis of data from South-West Scotland only, addition of mean monthly air quality 
indicators measured in Glasgow improved model performance (Supplementary File 6). This did 
not have a major bearing on the association between smoke-free legislation and acute RTI events: 
immediate change IRR 1.25, 95%CI 1.19-1.32; gradual change IRR 1.08 per year, 95%CI 1.06-
1.10.  
 
In further post-hoc analyses, the strength of association between timing of smoke-free legislation 
and acute RTI events was very similar when evaluated using a reg(S)ARIMA model of order 
AR(1,7) MAR(3,12): IRR 1.15, 95%CI 1.02-1.28. However, automatic breakpoint detection 
suggested that the increase in acute RTI events started well before introduction of smoke-free 
legislation – i.e. in November 2004 (Supplementary File 7). Using this breakpoint rather than 
timing of smoke-free legislation in the primary negative binomial regression analysis indeed 
improved model performance as compared to the primary model (Supplementary File 8). When 
timing of smoke-free legislation was then added to the model that included the November 2004 
breakpoint, smoke free legislation was associated with a gradual decrease in acute RTI events 
(IRR 0.91 per year, 95%CI 0.87-0.96), with no evidence of a ‘step’ change at that time (Table 2). 
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Table 2. Multivariable negative binomial regression model for acute respiratory tract 
infection events 
Characteristic Event rate ratio (ERR (95%CI)) 
Primary model 
(pre-specified) 
Post-hoc analysis 
Time (per year increase) 1.01 (1.01-1.01) 0.99 (0.99-1.00) 
Smoke-free legislation 1.24 (1.20-1.28)* Dropped from model 
based on AIC 
Time since smoke-free legislation (per year increase) 1.06 (1.05-1.06)* 0.91 (0.87-0.96)* 
November 2004 breakpoint Not in model 1.13 (1.08-1.19) 
Time since November 2004 breakpoint (per year 
increase) 
Not in model 1.16 (1.12-1.20) 
Month (reference = January)   
   February 0.83 (0.80-0.86) 0.83 (0.80-0.86) 
   March 0.78 (0.75-0.81) 0.78 (0.75-0.81) 
   April 0.54 (0.52-0.56) 0.54 (0.52-0.57) 
   May 0.52 (0.50-0.54) 0.52 (0.50-0.54) 
   June 0.46 (0.44-0.48) 0.46 (0.44-0.48) 
   July 0.33 (0.32-0.30) 0.33 (0.32-0.35) 
   August 0.29 (0.28-0.48) 0.29 (0.28-0.31) 
   September 0.47 (0.45-0.34) 0.47 (0.45-0.49) 
   October 0.57 (0.55-0.59) 0.57 (0.55-0.60) 
   November 0.84 (0.81-0.88) 0.85 (0.82-0.88) 
   December 1.26 (1.22-1.31) 1.27 (1.23-1.32) 
Male sex (reference = female) 1.31 (1.28-1.33) 1.31 (1.28-1.33) 
Age 5-12 years (reference = 0-4 years) 0.07 (0.07-0.08) 0.07 (0.07-0.08) 
Region (reference = North)   
   South-West 0.87 (0.85-0.89) 0.87 (0.85-0.89) 
   South-East 0.90 (0.89-0.92) 0.90 (0.89-0.92) 
Living in urban area (reference = rural) 0.99 (0.97-1.01) 0.99 (0.98-1.01) 
Socio-economic status (reference = Quintile 1; most 
affluent) 
  
   Quintile 2 1.11 (1.09-1.14) 1.11 (1.08-1.14) 
   Quintile 3 1.14 (1.11-1.17) 1.14 (1.11-1.17) 
   Quintile 4 1.25 (1.22-1.29) 1.25 (1.22-1.29) 
   Quintile 5 (most deprived) 1.35 (1.32-1.39) 1.35 (1.31-1.39) 
PCV vaccination received (reference = not received) 0.45 (0.43-0.46) 0.45 (0.43-0.46) 
Page 17 of 45
https://mc.manuscriptcentral.com/tobaccocontrol
Tobacco Control
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
18 
 
November 2003 (outlier) 1.48 (1.37-1.60) 1.61 (1.49-1.74) 
AIC = Akaike’s Information Criterion; PCV = pneumococcal conjugate vaccine 
The post-hoc analysis includes adjustment for an additional breakpoint in November 2004; 
*p<0.001 (p-value only indicated for smoke-free legislation indicators); PCV = pneumococcal 
conjugate vaccine; RTI = respiratory tract infection 
 
 
DISCUSSION 
 
In this large national ITS study conducted according to a pre-specified analysis plan, introduction 
of comprehensive smoke-free legislation in Scotland was associated with a significant increase in 
paediatric RTI events. Findings from our exploratory post-hoc analyses, which were undertaken 
to further investigate this unexpected finding, however indicated that the increase in RTI events 
most likely preceded the legislation by 16 months, making a direct causal link between the 
legislation and increased risk of RTIs implausible. 
 
Our study has a number of strengths. It was conducted according to a pre-defined protocol, 
including a detailed statistical analysis plan, which was developed a priori in an attempt to 
promote scientific transparency and reproducibility.[17] We used over 10 million patient-years of 
high-quality data routinely collected over a 17-year period. Virtual universal availability of the 
CHI number minimises risks of incorrect data linkage across the datasets. We accounted for 
underlying temporal trends in RTI events as well as changes in population size and demographic 
structure. We applied a look-back period to reduce bias from RTI events occurring prior to the 
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study period. Our modelling approach is widely applied in the evaluation of national public 
health interventions, including national smoke-free laws.[11,20,22,23]  
 
Given these strengths, the implausible findings are of considerable concern. It is important to 
consider the limitations of the study to see if these may have contributed to the observed findings. 
Allocation of a nationwide intervention cannot be randomised, and a quasi-experimental 
approach is considered a potentially valid method to evaluate impact such interventions.[15] Re-
analyses of cluster randomised controlled trials using an ITS approach have demonstrated that 
their findings can in fact be highly similar.[34-36] Whilst residual bias could possibly have 
influenced our findings,[14] we consider it unlikely that this would explain the implausible 
results of our primary analysis.  
 
Results of our pre-specified primary analysis were unanticipated and contradicted prior evidence 
on the topic.[10,12,19] Studies in other countries, including in the UK, previously identified 
consistent associations between comprehensive smoke-free legislation and subsequent reductions 
in paediatric RTI hospitalisations.[10,12,19] In line with these studies, there is consistent 
evidence for reductions in severe asthma exacerbations among children and in respiratory 
admissions among adults following implementation of smoke-free laws.[11,20,22] Post-hoc 
analyses showed that our findings were consistent across demographic subgroups and unlikely to 
have resulted from residual confounding by air pollution. As findings from ITS studies have 
previously been reported to be sensitive to choice of the modelling approach,[37] we performed 
additional aggregate-level times series analyses, again confirming the findings of our primary 
analysis. Automatic breakpoint detection is a method to explore whether a change in the 
incidence of the outcome under study indeed co-occurred with the known timing of the 
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intervention, and its use has been promoted as a routine validity test in single-group ITS 
analyses.[38] Using such an approach in a previous study, Kabir and colleagues were able to 
pinpoint timing of the observed reduction in small-for-gestational-age births to introduction of 
comprehensive smoke-free legislation in Ireland.[39] Using two different approaches and 
software packages to perform automatic breakpoint detection in our time series, the unanticipated 
increase in RTI events was shown to have preceded the smoke-free law by 16 months. This 
earlier breakpoint corresponds quite closely with temporal trends in paediatric RTI 
hospitalisations in England, which rose a consistently from 2003 onwards.[40] In a previous 
study, implementation of English comprehensive smoke-free legislation in 2007 was associated 
with a reduction in paediatric RTI admissions when accounting for this rising underlying 
trend.[10] This closely corresponds to the findings of our post-hoc analysis in Scotland, where 
RTI events were shown to increase consistently from 2004 onwards, this rise being attenuated 
after implementation of smoke-free legislation. Whereas an exploration of the underlying causes 
of the increasing trend in RTI events in Scotland was outside the scope of our study, several 
potential explanations for the corresponding rise in England have been postulated at the levels of 
the carer (e.g. decreasing threshold to take children to primary care or straight into hospital for 
evaluation), the health professional (e.g. decrease in threshold for r ferral by primary care doctors 
or for hospital admission), and the health care system (e.g. introduction of four-hour waiting 
target at emergency departments, unintended financial incentives for admission).[40] 
 
Perhaps the main value of this study therefore is that it uncovers a number of important 
methodological challenges, which have not previously received adequate attention in the applied 
ITS literature. We used advanced methods and followed a pre-specified analytical approach – 
including a detailed statistical analysis plan – in an attempt to promote transparency.[16,17,41] 
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Despite this, our study yielded findings which were implausible and highly likely to be spurious. 
We therefore conducted a number of exploratory post-hoc analyses, which added weight to our 
assessment that the findings of our primary analysis were indeed spurious. It is important to 
acknowledge that these post-hoc analyses were unlikely to have been conducted should the 
findings from our primary analysis have confirmed our initial hypothesis. In such a scenario, our 
study would still have biased the literature on the topic. 
 
At present, most public policy interventions remain unevaluated. ITS studies are arguably the 
most robust approaches we have at our disposal to evaluate the public health impact of these 
major experiments, which are seldom amendable to being implemented in a randomised 
fashion.[14] Despite their limitations, there is thus a need for many more ITS studies to be 
undertaken to continue to inform policy making at national, regional and global levels. To 
address the issues highlighted by our study, we propose that future ITS studies evaluating public 
health interventions should analyse the association under study using a number of different 
modelling approaches; ideally these should be pre-specified and include approaches based on 
both individual and aggregate level data (i.e. formal time series approaches). Also, we 
recommend that automatic breakpoint detection approaches are included to validate temporal co-
occurrence of the intervention and the change in the outcome under study. This and other 
machine learning approaches are likely to become increasingly applicable in discerning unusual 
patterns in time series data over and above variations due to natural changes and those explained 
by temporal, environmental, and individual-level confounding.[38] Confidence in the results 
from individual ITS studies can be further increased by reproducing findings in other settings, 
and interpreting findings from individual studies in the light of the totality of evidence on the 
topic. 
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Going back to the primary hypothesis under investigation, we are reluctant to draw firm 
conclusions on the impact of Scotland’s smoke-free legislation on paediatric RTIs given the 
inconsistent findings of the various analyses. Building on the existing evidence base on the 
topic,[20-24] we feel it is highly unlikely that smoke-free legislation was indeed responsible for a 
rise in paediatric RTI events, as our primary analyses seemed to suggest. On the other hand, 
given these findings it is also difficult to be confident that the result of our additional exploratory 
analyses – which were post hoc – provides a more valid representation of the actual impact of the 
legislation. 
 
Given the continuing need for formal quasi-experimental evaluations of public health 
interventions to inform policy making, we propose additional steps to improve the robustness of 
such studies, including: exploring the association between the intervention and outcome using a 
number of different (pre-specified) modelling approaches; analysing time series using both 
individual- and aggregate-level approaches; assessing for potential confounding by unmeasured 
factors; and using automatic breakpoint detection or alternative machine learning approaches to 
scrutinise findings from pre-specified primary analyses, irrespective of whether these support the 
underlying hypothesis. We hope that the lessons drawn from this experience will increase the 
validity of future ITS studies in the medical and public health literature. 
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Figure legend 
 
Figure 1. Monthly time series of acute respiratory tract infection (RTI) event rates. Dashed 
grey line indicates introduction of smoke-free legislation. 
 
 
Supplementary Files 
 
Supplementary File 1: Study protocol 
Supplementary File 2: List of ICD-10 codes 
Supplementary File 3: Table S1. Multivariable negative binomial regression model for acute 
upper and lower respiratory tract infection events 
Supplementary File 4: Table S2. Multivariable negative binomial regression model for acute 
respiratory tract infection events stratified according to sex 
Supplementary File 5: Table S3. Multivariable negative binomial regression model for acute 
respiratory tract infection events stratified according to age group 
Supplementary File 6: Table S4. Multivariable negative binomial regression model for acute 
respiratory tract infection events in South-East Scotland with adjustment for air quality 
Supplementary File 7: Figure S1. Automatic breakpoint detection in trimmed time series of 
acute respiratory tract infection (RTI) events. The likelihood ratio (LR) test statistic 
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maximises in November 2004, indicating the most likely breakpoint in the time series. 
Dashed grey line indicates introduction of smoke-free legislation. 
Supplementary File 8: Table S5. Multivariable negative binomial regression model for acute 
respiratory tract infection events with November 2004 breakpoint instead of timing of 
smoke-free legislation 
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Monthly time series of acute respiratory tract infection (RTI) event rates. Dashed grey line indicates 
introduction of smoke-free legislation.  
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Supplementary Text S1: Study protocol 
This study protocol was part of an application to the National Health Service National Services Scotland 
Privacy Advisory Committee (PAC 04/12 IR – XRB13092). 
 
What is the background to the study?   
Respiratory infections in childhood are one of the commonest reasons for hospital admission, primarily 
among infants. There is clear evidence that both antenatal and postnatal second-hand smoke (SHS) 
exposure increase the risk of respiratory infections among children. The relative contribution of SHS 
exposure to paediatric respiratory infections is greater than for childhood asthma, and adult lung cancer 
and cardiovascular disease for example. Worldwide the vast majority of the estimated 165,000 
childhood deaths each year associated with SHS exposure are due to respiratory infections. 
In Europe, over 50 percent of all children are regularly exposed to SHS. Particularly young children, who 
are most at risk of developing respiratory infections, have no means of controlling their own degree of 
SHS exposure and are therefore largely dependent on rules and regulations. However, despite World 
Health Organization (WHO) recommendations to implement smoke-free environments as part of a 
comprehensive approach to reduce SHS exposure, only 11% of countries had done so by 2010.  
 
Why is the study needed? 
Epidemiologic evaluations have shown reductions in asthma hospitalisations as well as preterm birth 
following the introduction of smoke-free legislation in different countries. To the best of our knowledge, 
the effect on respiratory tract infections has not been studied. Given the huge disease burden of 
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respiratory tract infections in childhood and the clear and important association between SHS exposure 
and respiratory infections in childhood, smoke-free legislation may carry important health benefit in this 
area. A better estimate of the range of effects that smoke-free legislation may have on paediatric health 
can serve as a mandate to further enhance the enforcement of measures to protect young people 
worldwide from the adverse effects of SHS exposure. 
 
What are the aims and objectives of the study?  
We aim to investigate the association between introduction of smoke-free legislation in Scotland (26 
March 2006) and incidence changes in hospitalisations for acute respiratory infections among children 
aged 0-12 years. 
 
Give a brief outline of the study design and data sources involved. 
Study design 
Interrupted time series  
Time period 
Hospitalisations or deaths associated with respiratory infections in children aged 12 years or under at 
that time occurring between January 1, 1996 and December 31, 2012 are included in the study.  
Population 
All first unplanned hospitalisations or deaths (together: ‘events’) associated with acute respiratory 
infections among children aged 12 years or under at that time are included in the given study period. A 
hospitalisation or death is considered to be associated with a respiratory infection if such is recorded as 
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either a primary or secondary diagnosis at the event. Deaths are included to account for children that 
died before reaching the hospital. Planned hospitalisations (e.g. for ear, nose, and throat (ENT) surgery) 
and hospitalisations for chronic upper respiratory infections are excluded. Furthermore, to prevent 
overlap with a previous study evaluating asthma hospitalisations (Mackay et al. NEJM 2010), all 
hospitalisation where asthma is recorded as the primary diagnosis are excluded. Children aged 13 years 
and above are excluded in an attempt to limit the potential confounding effect of self-smoking. 
Outcome 
The primary outcome is the number of first events associated with any acute respiratory infection. All 
hospitalisations and deaths where an acute respiratory tract infection is recorded as either a primary or a 
secondary diagnosis are included. Secondary outcomes include the number of events associated with 
acute upper respiratory tract infections, and the number of events associated with acute lower 
respiratory tract infections. A list of diagnostic international classification of diseases (ICD)-codes is 
attached as an appendix to the original protocol. 
In order to prevent dependency of data, only first events for each child will be included in the dataset. 
Subsequent hospitalisations or death in a child that has previously been hospitalised are thus excluded. 
For children entering the study at the start of the study period (i.e. 1 January 1996) a look back period of 
12 years will be applied to determine whether the child has experienced a hospitalisation for a 
respiratory infection prior to study entry. 
Covariates 
The following covariates will be included in the study: sex, age group, PCV immunisation status, month of 
admission, region, urban/rural setting, socioeconomic status (SES).  
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On 4 September 2006 PCV was introduced into the childhood immunisations schedule. Although the 
relative contribution of true pneumococcal infections to the total burden of admissions for respiratory 
infections, the majority of which is likely to be of viral aetiology, is expected to be small, the close 
temporal proximity of PCV introduction to that of the smoking ban necessitates adjustment for a 
potential confounding effect of vaccine exposure. Therefore SMR01 data will be linked to SIRS on an 
individual level and timed PCV immunisation status will be added as a potential confounder to the 
analyses.  
Three regions of residence will be considered based on the following grouping of local health boards: 
southwest (Ayrshire, Greater Glasgow and Clyde, Dumfries and Galloway, Lanarkshire), southeast 
(Lothian, Borders, Forth Valley), and north (Grampian, Highland, Tayside, Fife, Island). Urban or rural 
setting will be based on the 2006 Scottish Executive Urban Rural Classification system. SES will be 
categorised into quintiles according to the 2006 Scottish Index of Multiple Deprivation (SIMD). 
Dataset and items 
Data on emergency hospital admissions or deaths associated with respiratory infections will be extracted 
from the Scottish Morbidity Record 01 (SMR01). The following data items will be extracted: data of birth 
(DOB), sex (SEX), postcode (PC), hospital code (INSTCODE), admission date (ADMDATE), admission type 
(ADMTYPE), admission/transfer from (ADMTFM), main and secondary conditions (DG1-2), discharge type 
(DISTYPE). Data will be linked on an individual basis via the community health index (CHI) number to the 
Scottish Immunisation and Recall System (SIRS) for ascertainment of PCV immunisation status. 
Relevant data will be aggregated and provided in tabular form by ISD as follows. After data linkage on 
individual level, strata will be formed based on combinations of the different covariates (associated 
levels in brackets): sex (male/female); age group (<5 years/≥5 years); region 
(southwest/southeast/north); urbanisation level (urban/rural); SES (five quintiles as per SIMD); PCV 
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vaccination (yes/no); month (12 levels); year (1996-2012: 17 levels). Thus, 2×2×3×2×5×2×12×17=48,960 
strata are formed. Event counts as well as population counts will be calculated and provided for each 
stratum. A table demonstrating final data structure is attached as an appendix to the original study 
protocol. 
Sample size 
Sample size calculation for time-oriented analyses is complicated given the complexity of the models, 
and in a way redundant given that nationwide data are being used for the current study. To the best of 
our knowledge, no prior studies in any other region have evaluated changes in the number of hospital 
admissions for respiratory infections among children following the introduction of smoke-free 
legislation.  
In a previous epidemiological evaluation of the Scottish smoking ban a highly significant (p<0.001) annual 
drop in asthma hospitalisations of 13% was found among children <15 years of age. Meta-analyses of 
observational studies indicate that second hand smoke exposure is associated with higher risk of 
respiratory tract infections in infancy (OR 1.54 (95% CI 1.40-1.69) for lower respiratory tract infections in 
infancy and 1.62 (95% CI 1.33-1.97) for middle ear disease in childhood) when compared to incident and 
current asthma in children (OR 1.21 (95% CI 1.08-1.36), and 1.30 (95% CI 1.22-1.39), respectively). This 
indicates that smoke-free legislation is likely to have a larger effect on acute respiratory infections than 
asthma. Furthermore, paediatric hospital admissions for acute respiratory infections are more common 
than for asthma, and the study period for the current study is longer than compared to the previous 
asthma study. Therefore, we expect the current study to have ample power to detect a significant and 
clinically relevant drop in hospitalisations for respiratory infections, if present. 
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Statistical analyses 
Univariate analyses 
Population-level incidence trends (‘counts’) will be plotted over time to identify any apparent temporal 
changes. Interrupted time series analysis using negative binomial regression will be used to study the 
association of time trends in the outcomes of interest and introduction of smoke-free legislation. The 
analyses will allow for a sudden (‘step’) and a trend (‘slope’) change in incidence trends of each of the 
outcomes following 26 March 2006 (i.e. when the smoking ban came into force). Stratum-specific mid-
year population estimates will be used to define the denominator for the analyses. 
Multivariate analyses 
Potential confounding will be adjusted for by formation of demographic subgroups and subsequent 
stratified analysis. Potential confounders include: sex, age, PCV immunisation status, region, urban/rural 
setting, and SES. Month of admission will be added to the model to account for seasonal variation in 
hospital admissions for respiratory infections. Aikake’s and Bayesian information criterions will be used 
for final model selection. A combination of Hosmer-Lemeshow statistic and receiver operating 
characteristic (ROC)-curves will be used to assess model performance for logistic regression models. 
Software 
All analyses will be performed using Stata 12.1. 
Page 37 of 45
https://mc.manuscriptcentral.com/tobaccocontrol
Tobacco Control
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
Supplemental File 2:  
International Classification of Diseases (ICD)-10 codes used to define respiratory tract infection (RTI) 
events 
 
upper RTIs:  
A37  whooping cough 
H66/67  suppurative and unspecified otitis media 
J00  acute nasopharyngitis 
J01  acute sinusitis 
J02  acute pharyngitis 
J03  acute tonsillitis 
J04  acute laryngitis 
J05  acute tracheitis 
J06  acute upper respiratory infections of multiple or unspecified sites 
J09-11 (not J10.0/J11.0) influenza 
 
lower RTIs:  
J10.0/J11.0 influenza with pneumonia 
J12  viral pneumonia 
J13  pneumococcal pneumonia 
J14/15  other bacterial pneumonia 
J16/17  pneumonia due to other specified organism 
J18  pneumonia, organism unspecified 
J20  acute bronchitis 
J21  acute bronchiolitis 
J22  unspecified acute lower respiratory infection 
J40/41/42 bronchitis 
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Supplementary Table S1. Multivariable negative binomial regression model for acute upper and lower 
respiratory tract infection events 
Characteristic Event rate ratio (ERR (95%CI)) 
Acute upper RTIs Acute lower RTIs 
Time (per year increase) 1.01 (1.00-1.01) 1.02 (1.01-1.03) 
Smoke-free legislation 1.22 (1.19-1.26)* 1.23 (1.18-1.30)* 
Time since smoke-free legislation (per year increase) Dropped from 
model based on 
AIC 
1.12 (1.11-1.13)* 
Month (reference = January)   
   February 0.98 (0.94-1.02) 0.71 (0.67-0.75) 
   March 1.07 (1.03-1.11) 0.53 (0.51-0.56) 
   April 0.81 (0.78-0.84) 0.32 (0.30-0.33) 
   May 0.82 (0.79-0.86) 0.27 (0.25-0.28) 
   June 0.75 (0.72-0.79) 0.21 (0.20-0.23) 
   July 0.56 (0.53-0.58) 0.14 (0.13-0.15) 
   August 0.48 (0.46-0.50) 0.13 (0.12-0.14) 
   September 0.76 (0.72-0.79) 0.22 (0.21-0.24) 
   October 0.86 (0.82-0.89) 0.33 (0.31-0.35) 
   November 0.96 (0.92-1.00) 0.75 (0.71-0.79) 
   December 1.16 (1.11-1.20) 1.35 (1.29-1.41) 
Male sex (reference = female) 1.33 (1.31-1.36) 1.25 (1.22-1.29) 
Age 5-12 years (reference = 0-4 years) 0.10 (0.09-0.10) 0.05 (0.05-0.05) 
Region (reference = North)   
   South-West 0.85 (0.84-0.87) 0.87 (0.84-0.89) 
   South-East 0.81 (0.79-0.83) 1.04 (1.01-1.08) 
Living in urban area (reference = rural) 1.00 (0.97-1.02) 1.00 (0.97-1.03) 
Socio-economic status (reference = Quintile 1)   
   Quintile 2 1.14 (1.11-1.17) 1.06 (1.02-1.11) 
   Quintile 3 1.16 (1.13-1.20) 1.10 (1.05-1.14) 
   Quintile 4 1.30 (1.26-1.34) 1.18 (1.13-1.22) 
   Quintile 5 (most deprived) 1.33 (1.30-1.38) 1.34 (1.28-1.39) 
PCV vaccination received (reference = not received) 0.69 (0.67-0.72) 0.23 (0.22-0.24) 
Nov 2003 (outlier) 1.95 (1.77-2.14) Not in model 
 
*p<0.001 (p-value only indicated for smoke-free legislation indicators); PCV = pneumococcal conjugate 
vaccine; RTI = respiratory tract infection 
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Supplementary Table S2. Multivariable negative binomial regression model for acute respiratory tract 
infection events stratified according to sex 
Characteristic Event rate ratio (ERR (95%CI)) 
Males Females 
Time (per year increase) 1.01 (1.01-1.01) 1.02 (1.01-1.02) 
Smoke-free legislation 1.23 (1.18-1.28)* 1.26 (1.20-1.31)* 
Time since smoke-free legislation (per year increase) 1.06 (1.05-1.07)* 1.05 (1.04-1.06)* 
Month (reference = January)   
   February 0.84 (0.80-0.88) 0.82 (0.78-0.87) 
   March 0.80 (0.76-0.84) 0.76 (0.72-0.80) 
   April 0.56 (0.53-0.59) 0.51 (0.49-0.54) 
   May 0.55 (0.52-0.58) 0.48 (0.46-0.51) 
   June 0.50 (0.47-0.53) 0.41 (0.39-0.44) 
   July 0.34 (0.33-0.36) 0.31 (0.29-0.33) 
   August 0.30 (0.29-0.32) 0.27 (0.25-0.29) 
   September 0.51 (0.48-0.54) 0.41 (0.39-0.44) 
   October 0.61 (0.58-0.64) 0.52 (0.49-0.55) 
   November 0.87 (0.82-0.92) 0.82 (0.77-0.86) 
   December 1.29 (1.23-1.35) 1.24 (1.17-1.30) 
Age 5-12 years (reference = 0-4 years) 0.07 (0.07-0.07) 0.08 (0.08-0.08) 
Region (reference = North)   
   South-West 0.87 (0.85-0.89) 0.87 (0.85-0.90) 
   South-East 0.91 (0.89-0.94) 0.89 (0.87-0.92) 
Living in urban area (reference = rural) 0.99 (0.97-1.02) 0.99 (0.96-1.02) 
Socio-economic status (reference = Quintile 1)   
   Quintile 2 1.12 (1.08-1.16) 1.10 (1.06-1.14) 
   Quintile 3 1.14 (1.11-1.18) 1.14 (1.10-1.18) 
   Quintile 4 1.24 (1.20-1.28) 1.27 (1.23-1.32) 
   Quintile 5 (most deprived) 1.32 (1.27-1.36) 1.40 (1.34-1.45) 
PCV vaccination received (reference = not received) 0.43 (0.41-0.45) 0.47 (0.44-0.49) 
Nov 2003 (outlier) 1.43 (1.29-1.58) 1.55 (1.39-1.73) 
 
*p<0.001 (p-value only indicated for smoke-free legislation indicators); PCV = pneumococcal conjugate 
vaccine 
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Supplementary Table S3. Multivariable negative binomial regression model for acute respiratory tract 
infection events stratified according to age group 
Characteristic Event rate ratio (ERR (95%CI)) 
Age = 0-4 years Age = 5-12 years 
Time (per year increase) 1.01 (1.01-1.02) 1.02 (1.01-1.03) 
Smoke-free legislation 1.30 (1.25-1.35)* 1.36 (1.27-1.45)* 
Time since smoke-free legislation (per year increase) 1.08 (1.07-1.08)* 0.90 (0.89-0.92)* 
Month (reference = January)   
   February 0.79 (0.76-0.82) 1.03 (0.95-1.12) 
   March 0.72 (0.70-0.75) 1.11 (1.03-1.20) 
   April 0.51 (0.49-0.53) 0.66 (0.61-0.72) 
   May 0.48 (0.46-0.50) 0.70 (0.65-0.76) 
   June 0.41 (0.40-0.43) 0.72 (0.66-0.78) 
   July 0.30 (0.29-0.31) 0.50 (0.46-0.55) 
   August 0.26 (0.25-0.28) 0.44 (0.41-0.48) 
   September 0.42 (0.40-0.44) 0.74 (0.68-0.80) 
   October 0.53 (0.51-0.55) 0.78 (0.72-0.85) 
   November 0.82 (0.78-0.85) 0.98 (0.91-1.06) 
   December 1.27 (1.22-1.32) 1.23 (1.14-1.32) 
Male sex (reference = female) 1.34 (1.32-1.35) 1.17 (1.13-1.21) 
Region (reference = North)   
   South-West 0.88 (0.86-0.90) 0.85 (0.82-0.89) 
   South-East 0.91 (0.89-0.93) 0.89 (0.85-0.93) 
Living in urban area (reference = rural) 0.99 (0.87-1.02) 0.98 (0.94-1.02) 
Socio-economic status (reference = Quintile 1)   
   Quintile 2 1.10 (1.07-1.13) 1.15 (1.09-1.22) 
   Quintile 3 1.12 (1.09-1.15) 1.22 (1.15-1.29) 
   Quintile 4 1.23 (1.20-1.27) 1.31 (1.24-1.38) 
   Quintile 5 (most deprived) 1.34 (1.30-1.38) 1.36 (1.29-1.44) 
PCV vaccination received (reference = not received) 0.38 (0.37-0.40) 2.14 (1.98-2.32) 
Nov 2003 (outlier) 1.53 (1.40-1.66) 1.33 (1.10-1.61) 
 
*p<0.001 (p-value only indicated for smoke-free legislation indicators); PCV = pneumococcal conjugate 
vaccine 
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Supplementary Table S4. Multivariable negative binomial regression model for acute respiratory tract 
infection events in South-East Scotland with adjustment for air quality 
Characteristic Event rate ratio 
(ERR (95%CI)) 
Time (per year increase) 0.99 (0.98-1.01) 
Smoke-free legislation 1.25 (1.19-1.32)* 
Time since smoke-free legislation (per year increase) 1.08 (1.06-1.10)* 
Month (reference = January)  
   February 0.82 (0.76-0.87) 
   March 0.76 (0.71-0.82) 
   April 0.53 (0.49-0.58) 
   May 0.52 (0.48-0.57) 
   June 0.44 (0.40-0.48) 
   July 0.32 (0.29-0.35) 
   August 0.26 (0.24-0.29) 
   September 0.43 (0.39-0.46) 
   October 0.54 (0.50-0.58) 
   November 0.80 (0.74-0.86) 
   December 1.26 (1.18-1.36) 
Male sex (reference = female) 1.30 (1.26-1.33) 
Age 5-12 years (reference = 0-4 years) 0.08 (0.08-0.08) 
Living in urban area (reference = rural) 0.83 (0.80-0.86) 
Socio-economic status (reference = Quintile 1)  
   Quintile 2 1.17 (1.12-1.23) 
   Quintile 3 1.29 (1.23-1.35) 
   Quintile 4 1.41 (1.35-1.47) 
   Quintile 5 (most deprived) 1.38 (1.32-1.44) 
PCV vaccination received (reference = not received) 0.50 (0.48-0.54) 
Air quality indicators  
   Carbon monoxide (CO; per mg/m3) 0.88 (0.74-1.03) 
   Nitric oxide (NO; per µg/m3) 0.95 (0.93-0.97) 
   Nitrogen dioxide (NO2; per µg/m3) 0.96 (0.95-0.98) 
   Nitrogen oxides as NO2 (per µg/m3) 1.03 (1.02-1.05) 
   Sulphur dioxide (SO2; per µg/m3) 0.99 (0.99-1.00) 
   Ozone (O3; per µg/m3) 0.99 (0.99-1.00) 
   Particulate matter of diameter <10µm (PM10; per µg/m3) 1.01 (1.00-1.01) 
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*p<0.001 (p-value only indicated for smoke-free legislation indicators); PCV = pneumococcal conjugate 
vaccine  
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Supplementary Table S5. Multivariable negative binomial regression model for acute respiratory tract 
infection events with November 2004 breakpoint instead of timing of smoke-free legislation 
Characteristic Event rate ratio (ERR 
(95%CI)) 
Time (per year increase) 0.99 (0.99-1.00) 
Smoke-free legislation Not in model 
Time since smoke-free legislation (per year increase) Not in model 
November 2004 breakpoint 1.23 (1.20-1.27)* 
Time since November 2004 breakpoint (per year increase) 1.08 (1.07-1.09)* 
Month (reference = January)  
   February 0.83 (0.80-0.86) 
   March 0.78 (0.75-0.81) 
   April 0.54 (0.53-0.57) 
   May 0.52 (0.51-0.54) 
   June 0.46 (0.45-0.48) 
   July 0.33 (0.32-0.35) 
   August 0.29 (0.28-0.31) 
   September 0.47 (0.45-0.49) 
   October 0.58 (0.55-0.60) 
   November 0.85 (0.82-0.89) 
   December 1.27 (1.22-1.31) 
Male sex (reference = female) 1.30 (1.28-1.33) 
Age 5-12 years (reference = 0-4 years) 0.07 (0.07-0.08) 
Region (reference = North)  
   South-West 0.87 (0.85-0.89) 
   South-East 0.90 (0.89-0.93) 
Living in urban area (reference = rural) 0.99 (0.98-1.01) 
Socio-economic status (reference = Quintile 1)  
   Quintile 2 1.11 (1.09-1.14) 
   Quintile 3 1.14 (1.11-1.17) 
   Quintile 4 1.25 (1.22-1.29) 
   Quintile 5 (most deprived) 1.35 (1.31-1.39) 
PCV vaccination received (reference = not received) 0.45 (0.43-0.46) 
Nov 2003 (outlier) 1.61 (1.49-1.74) 
 
*p<0.001 (p-value only indicated for smoke-free legislation indicators); PCV = pneumococcal conjugate 
vaccine  
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